×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ALXO – alx oncology holdings inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ALXO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/19
09:07 am
alxo
Yahoo Finance [Yahoo! Finance]
High
Report
Yahoo Finance [Yahoo! Finance]
12/19
07:42 am
alxo
ALX Oncology Holdings Inc. (NASDAQ: ALXO) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating. They now have a $2.00 price target on the stock, down previously from $12.00.
High
Report
ALX Oncology Holdings Inc. (NASDAQ: ALXO) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating. They now have a $2.00 price target on the stock, down previously from $12.00.
12/18
09:19 am
alxo
ALX Oncology Holdings Inc. (NASDAQ: ALXO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Low
Report
ALX Oncology Holdings Inc. (NASDAQ: ALXO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
12/18
08:14 am
alxo
ALX Oncology to Present Updated Results from Phase 2 ASPEN-06 Clinical Trial of Evorpacept in Patients with HER2-Positive Gastric Cancer in Oral Presentation at 2025 ASCO Gastrointestinal Cancers Symposium [Yahoo! Finance]
Low
Report
ALX Oncology to Present Updated Results from Phase 2 ASPEN-06 Clinical Trial of Evorpacept in Patients with HER2-Positive Gastric Cancer in Oral Presentation at 2025 ASCO Gastrointestinal Cancers Symposium [Yahoo! Finance]
12/18
08:07 am
alxo
ALX Oncology Holdings Inc. (NASDAQ: ALXO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
Low
Report
ALX Oncology Holdings Inc. (NASDAQ: ALXO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
12/18
08:00 am
alxo
ALX Oncology to Present Updated Results from Phase 2 ASPEN-06 Clinical Trial of Evorpacept in Patients with HER2-Positive Gastric Cancer in Oral Presentation at 2025 ASCO Gastrointestinal Cancers Symposium
Low
Report
ALX Oncology to Present Updated Results from Phase 2 ASPEN-06 Clinical Trial of Evorpacept in Patients with HER2-Positive Gastric Cancer in Oral Presentation at 2025 ASCO Gastrointestinal Cancers Symposium
12/12
08:17 am
alxo
ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at SABCS 2024 [Yahoo! Finance]
Medium
Report
ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at SABCS 2024 [Yahoo! Finance]
12/12
08:00 am
alxo
ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at SABCS 2024
Low
Report
ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at SABCS 2024
Date
Time
Symbol
Company Name
Action
%Chg
11/7/2024
04:00 pm
alxo
alx oncology holdings inc.
BEAT
Report
-4.6%
alx oncology holdings inc.
8/8/2024
04:05 pm
alxo
alx oncology holdings inc.
BEAT
Report
-0.8%
alx oncology holdings inc.
5/9/2024
04:00 pm
alxo
alx oncology holdings inc.
BEAT
Report
-4.4%
alx oncology holdings inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/6
11:34 am
alxo
Form SCHEDULE 13G/A ALX ONCOLOGY HOLDINGS Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A ALX ONCOLOGY HOLDINGS Filed by: FMR LLC
12/4
04:17 pm
alxo
Form 4 ALX ONCOLOGY HOLDINGS For: Dec 02 Filed by: Hemrajani Rekha
High
Report
Form 4 ALX ONCOLOGY HOLDINGS For: Dec 02 Filed by: Hemrajani Rekha
12/4
04:16 pm
alxo
Form 4 ALX ONCOLOGY HOLDINGS For: Dec 02 Filed by: Pinto Shelly
High
Report
Form 4 ALX ONCOLOGY HOLDINGS For: Dec 02 Filed by: Pinto Shelly
12/4
04:13 pm
alxo
Form 4 ALX ONCOLOGY HOLDINGS For: Dec 02 Filed by: Lettmann Jason
High
Report
Form 4 ALX ONCOLOGY HOLDINGS For: Dec 02 Filed by: Lettmann Jason
12/2
04:07 pm
alxo
Form SC TO-I ALX ONCOLOGY HOLDINGS Filed by: ALX ONCOLOGY HOLDINGS INC
Medium
Report
Form SC TO-I ALX ONCOLOGY HOLDINGS Filed by: ALX ONCOLOGY HOLDINGS INC
11/19
04:06 pm
alxo
Form 4 ALX ONCOLOGY HOLDINGS For: Nov 18 Filed by: Sandler Alan B.
Low
Report
Form 4 ALX ONCOLOGY HOLDINGS For: Nov 18 Filed by: Sandler Alan B.
11/14
07:23 pm
alxo
Form SC 13G/A ALX ONCOLOGY HOLDINGS Filed by: ORBIMED ADVISORS LLC
Medium
Report
Form SC 13G/A ALX ONCOLOGY HOLDINGS Filed by: ORBIMED ADVISORS LLC
11/14
06:58 pm
alxo
Form SC 13G/A ALX ONCOLOGY HOLDINGS Filed by: Vivo Capital Fund IX, L.P.
Medium
Report
Form SC 13G/A ALX ONCOLOGY HOLDINGS Filed by: Vivo Capital Fund IX, L.P.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: